LD-2 disclosure · 1st Quarter - Report
FERRING PHARMACEUTICALS INC.
Client
- Name
- FERRING PHARMACEUTICALS INC.
- Description
- biopharmaceutical company
- Location
- New Jersey · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit
LobbyistsDAVID REID · HAROLD HANCOCK · EMILY FELDER · ADAM STEINMETZ · MARK L. PRYOR · mr EDWARD RANDALL ROYCE · DEEMA TARAZI · BRANDT ANDERSON · JONATHAN TOWERS
Covered position (DAVID REID): None
Covered position (MARK L. PRYOR): United States Senator
Covered position (mr EDWARD RANDALL ROYCE): Representative, U.S. House of Representatives
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP)
Veterans
Issues related to veteran's care and veteran's reproductive care
LobbyistsJONATHAN TOWERS
Trade (domestic/foreign)
Issues related to pharmaceutical tariffs
LobbyistsEMILY FELDER · mr JOSEPH BRADY HOWELL · TIM SHADYAC · AARON CUMMINGS
SENATE · Executive Office of the President (EOP) · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC) · Bureau of Industry and Security (BIS)